Fig. 3From: Irinotecan-gut microbiota interactions and the capability of probiotics to mitigate Irinotecan-associated toxicityDifferential abundance using (a) ANCOM analysis plot, showing the abundance of Bacteroidales in the healthy group, and using (b) DESeq2 analysis, showing the phylum Verrucomicrobia as the most significant marker in the healthy groupBack to article page